MedTrace Logo

Performance Study of SONA Saliva C-19 Rapid Test

NCT04877002 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2023-03-24

No results posted yet for this study

Summary

The Sona Saliva C-19 Rapid Test is a bioassay intended for rapid point-of-care detection of the SARS-CoV-2 virus. Performance of the Sona Saliva C-19 Rapid Test assay will be assessed by comparison to a RT-PCR reference method

Conditions

Interventions

DIAGNOSTIC_TEST

Sona Saliva C-19 Rapid Test

Rapid Antigen diagnostic device performance comparative to RT-PCR

Sponsors & Collaborators

  • Sona Nanotech Inc

    lead INDUSTRY

Principal Investigators

  • David Jacobs, Dr · Humber River Hospital

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-04-29
Primary Completion
2021-06-10
Completion
2022-01-05

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04877002 on ClinicalTrials.gov